Clincosm LogoSign in Get a demo

Locally Advanced Breast Cancer

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic

Recruiting
  • Locally Advanced Breast Cancer
  • Modified radical mastectomy for breast cancer
  • +2 more
  • Beijing, China
    Ying Xu
Oct 6, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Orange City, Florida
  • +27 more
Jul 19, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Early-stage Breast Cancer, Locally Advanced Breast Cancer Trial in Singapore (Exercise Programme, Control)

Recruiting
  • Early-stage Breast Cancer
  • Locally Advanced Breast Cancer
  • Exercise Programme
  • Control
  • Singapore, Singapore
  • +2 more
Jul 19, 2023

Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)

Recruiting
  • Locally Advanced Breast Cancer
  • Hormone Receptor Positive，HER2-negative Breast Cancer
  • Jinan, Shandong, China
    Breast Cancer Center, Shandong Cancer Hospital and Institute
Apr 11, 2023

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)

Not yet recruiting
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • Cádiz, Andalucía, Spain
  • +18 more
Feb 24, 2023

Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer Trial in Canada, Mexico, Spain (drug, procedure,

Recruiting
  • Early Breast Cancer
  • +2 more
  • Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)
  • +6 more
  • Buenos Aires, Argentina
  • +29 more
Jan 31, 2023

Real-World Data of Clinicopathological Characteristics and

Recruiting
  • Early Breast Cancer
  • +2 more
    • Barcelona, Spain
    • +9 more
    Jan 18, 2023

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Manchester, Greater Manchester, United Kingdom
    • +6 more
    Jan 5, 2023

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

    Withdrawn
    • Triple Negative Breast Cancer
    • +4 more
    • Aurora, Colorado
      University of Colorado Hospital
    Dec 2, 2022

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Breast Cancer, Locally Advanced Breast Cancer Trial in United States (Sentinel Lymph Node Biopsy (SLNB))

    Recruiting
    • Breast Cancer
    • Locally Advanced Breast Cancer
    • Sentinel Lymph Node Biopsy (SLNB)
    • Miami, Florida
    • +7 more
    Nov 7, 2022

    Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

    Recruiting
    • Breast Cancer
    • +9 more
    • Boston, Massachusetts
    • +2 more
    Oct 25, 2022

    Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

    Not yet recruiting
    • Breast Neoplasm
    • +9 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Oct 13, 2022

    Locally Advanced Breast Cancer Trial in Shanghai (pyrotinib)

    Recruiting
    • Locally Advanced Breast Cancer
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
    Aug 11, 2022

    Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (U3-1402)

    Recruiting
    • Metastatic Breast Cancer
    • Locally Advanced Breast Cancer
    • Birmingham, Alabama
    • +9 more
    Jul 18, 2022

    Human Epidermal Growth Factor Receptor 2-Positive Unresectable

    Active, not recruiting
    • Metastatic Breast Cancer
    • Locally Advanced Breast Cancer
      • Athens, Greece
      • +1 more
      Jun 20, 2022

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Durham, North Carolina
        Duke University Medical Center
      Jun 7, 2022

      Solid Tumor, Extensive-stage Small-cell Lung Cancer, Locally Advanced Breast Cancer Trial in Czechia, Poland (RP12146)

      Recruiting
      • Solid Tumor
      • +6 more
      • Hořovice, Czechia
      • +5 more
      Jun 8, 2022

      Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Batumi, Tbilisi (Tenalisib)

      Active, not recruiting
      • Locally Advanced Breast Cancer
      • Metastatic Breast Cancer
      • Batumi, Georgia
      • +2 more
      May 2, 2022

      Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer Trial in Korea, Republic of, United States (ZB716,

      Recruiting
      • Estrogen Receptor-Positive
      • +3 more
      • Seattle, Washington
      • +7 more
      Mar 20, 2022

      Circulating Tumor Cells in Locally Advanced or Metastatic Stage

      Active, not recruiting
      • Locally Advanced Breast Cancer
      • +2 more
        • Duarte, California
          City of Hope Medical Center
        Mar 16, 2022

        Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

        Recruiting
        • Metastatic Breast Carcinoma
        • +13 more
        • 68GaNOTA-Anti-HER2 VHH1
        • Brussels, Brussel, Belgium
          Uz Brussel
        Dec 17, 2021